Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 10.7789 | 99 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 10.9367 | 99 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 10.7924 | 99 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 10.8028 | 98 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 10.7321 | 98 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 10.7073 | 99 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 10.5841 | 99 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 10.5702 | 98 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 10.5067 | 98 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 10.6934 | 99 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 10.6633 | 99 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 10.7104 | 98 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 10.6982 | 99 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 10.705 | 99 |